Skip to main content
Signal8

Wolterman Dan

SEC insider (Form 3/4/5 filer). CIK 0001586330. Director at Hyperfine, Inc. (HYPR) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in GUILFORD, CT.

Companies Wolterman Dan has filed insider reports for

  • Hyperfine, Inc. (HYPR): Director
  • GLOBUS MEDICAL INC (GMED): Director
Wolterman Dan profile photo

Wolterman Dan

CIK: 0001586330

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Hyperfine, Inc. logo
HYPR

Hyperfine, Inc.

Director
GLOBUS MEDICAL INC logo
GMED

GLOBUS MEDICAL INC

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Hyperfine, Inc. logo
    HYPR

    Hyperfine, Inc.

    Jun 3, 2026
    Award

    Stock Options (right to buy)

    Direct
    52.6K shares-
  • Hyperfine, Inc. logo
    HYPR

    Hyperfine, Inc.

    May 22, 2026
    Award

    Stock Options (right to buy)

    Direct
    157.7K shares-
  • GLOBUS MEDICAL INC logo
    GMED

    GLOBUS MEDICAL INC

    Jan 21, 2026
    Award

    Stock Option (Right to Buy Class A Common Stock)

    Direct
    15K shares-
  • Hyperfine, Inc. logo
    HYPR

    Hyperfine, Inc.

    Jun 5, 2025
    Award

    Stock Options (right to buy)

    Direct
    81.8K shares-
  • Hyperfine, Inc. logo
    HYPR

    Hyperfine, Inc.

    May 20, 2025
    Award

    Stock Options (right to buy)

    Direct
    79.2K shares-
  • GLOBUS MEDICAL INC logo
    GMED

    GLOBUS MEDICAL INC

    Jan 23, 2025
    Award

    Stock Option (Right to Buy Class A Common Stock)

    Direct
    15K shares-

1-6 of 6